Prescription drug · ANDA
Aprepitant NDC 13668-594
Kit · Torrent Pharmaceuticals Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 13668-594-87 | 1366805948713668059487 | 1 KIT in 1 DOSE PACK (13668-594-87) * 2 CAPSULE in 1 BLISTER PACK * 1 CAPSULE in 1 BLISTER PACKMarketed from Oct 21, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Aprepitant
- Generic name (nonproprietary)
- aprepitant
- Dosage form
- Kit
- Labeler
- Torrent Pharmaceuticals LimitedNDC labeler code 13668
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211835
- Marketing start
- Listing expires
- Identifiers
- Product ID 13668-594_d61cf041-fb75-4b56-949d-1f2f93acf4d0SPL ID d61cf041-fb75-4b56-949d-1f2f93acf4d0SPL set ID af9b6086-4bf2-472c-8740-4134eaaebaceRxCUI 403810, 403811, 644088, 754508UNII 1NF15YR6UY
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N413668059487followed by a unit qualifier and the quantityPackage 13668-0594-87. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Aprepitant is a substance P/neurokinin 1 (NK1) receptor antagonist. Aprepitant capsules are indicated • in combination with other antiemetic agents, in patients 12 years of age and older for prevention of: o acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin ( 1.1 ) o nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC) ( 1.1 ) • for prevention of postoperative nausea and vomiting (PONV) in adults ( 1.2 ) Limitations of Use : ( 1.3 ) • Aprepitant has not been studied for treatment of established nausea and vomiting. • Chronic …
Excerpt only. Read the full label for complete information.
About NDC 13668-594
- What is NDC 13668-594?
- 13668-594 is the product NDC for Aprepitant kit, listed with the FDA by Torrent Pharmaceuticals Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Aprepitant.
- Who is the labeler?
- Torrent Pharmaceuticals Limited, NDC labeler code 13668. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Aprepitant?
- 19 other product NDCs are listed under this name. See all Aprepitant NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Aprepitant products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Aprepitant | Aprepitant 125 mg/1 | CapsuleOral | BluePoint Laboratories | 68001-668 | 68001-0668-19 |
| Aprepitant | — | Kit | BluePoint Laboratories | 68001-669 | 68001-0669-15 |
| Aprepitant | Aprepitant 40 mg/1 | CapsuleOral | BluePoint Laboratories | 68001-666 | 68001-0666-0168001-0666-17 |
| Aprepitant | Aprepitant 80 mg/1 | CapsuleOral | BluePoint Laboratories | 68001-667 | 68001-0667-0168001-0667-19 |
| Aprepitant | Aprepitant 40 mg/1 | CapsuleOral | Torrent Pharmaceuticals Limited | 13668-591 | 13668-0591-8113668-0591-82 |
| Aprepitant | Aprepitant 80 mg/1 | CapsuleOral | Torrent Pharmaceuticals Limited | 13668-592 | 13668-0592-8413668-0592-86 |
| Aprepitant | Aprepitant 125 mg/1 | CapsuleOral | Torrent Pharmaceuticals Limited | 13668-593 | 13668-0593-86 |
| Aprepitant | Aprepitant 40 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-701 | 51407-0701-0151407-0701-05 |
| Aprepitant | Aprepitant 80 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-702 | 51407-0702-0251407-0702-06 |
| Aprepitant | Aprepitant 125 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-703 | 51407-0703-06 |
Other NDCs under ANDA 211835
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Aprepitant | Aprepitant 40 mg/1 | CapsuleOral | Torrent Pharmaceuticals Limited | 13668-591 |
| Aprepitant | Aprepitant 80 mg/1 | CapsuleOral | Torrent Pharmaceuticals Limited | 13668-592 |
| Aprepitant | Aprepitant 125 mg/1 | CapsuleOral | Torrent Pharmaceuticals Limited | 13668-593 |
| Aprepitant | Aprepitant 40 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-701 |
| Aprepitant | Aprepitant 80 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-702 |
| Aprepitant | Aprepitant 125 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-703 |
| Aprepitant | — | Kit | Golden State Medical Supply, Inc. | 51407-704 |